Moderna
MRNA
#1191
Rank
HK$122.07 B
Marketcap
HK$317.23
Share price
-9.39%
Change (1 day)
-61.28%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2023 (TTM): -HK$71.67

According to Moderna 's latest financial reports the company's current EPS (TTM) is -HK$71.21. In 2022 the company made an earnings per share (EPS) of HK$164.54 a decrease over its 2021 EPS that were of HK$235.90.

EPS history for Moderna from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$71.67-143.56%
2022HK$164.54-30.25%
2021HK$235.90-1660.82%
2020-HK$15.1125.16%
2019-HK$12.0837.04%
2018-HK$8.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$13.17-81.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.19-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$23.61-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$32.02-55.03%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$29.14-140.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-HK$13.24-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.73-254.11%๐Ÿ‡บ๐Ÿ‡ธ USA